dcgi: After crackdown on spurious medicines, India's drug regulator collating data of pharma plants
The companies have also been asked to share information on international approvals obtained from the European Union, US Food and Drug Administration, Japans Pharmaceuticals and Medical Devices Agency, Brazilian Health Regulatory Agency (Anvisa), among other regulatory bodies abroad.
New Delhi Devices Agency Healthcare Management Analytics Programme Brazilian Health Regulatory Agency Anvisa European Union Indian School Of Business
Source: indiatimes.com